EditorialEditorial
The Need for Biological Outcomes for Biological Drugs in Psoriatic Arthritis
AI LYN TAN and DENNIS McGONAGLE
The Journal of Rheumatology January 2016, 43 (1) 3-6; DOI: https://doi.org/10.3899/jrheum.151296
AI LYN TAN
Professor in Regenerative Medicine,
UK National Institute for Health Research Leeds Musculoskeletal Biomedical Research Unit, Chapel Allerton Hospital, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds,
UK.
MD, MRCPRoles: Associate Professor and Consultant in Rheumatology
DENNIS McGONAGLE
Professor in Regenerative Medicine,
UK National Institute for Health Research Leeds Musculoskeletal Biomedical Research Unit, Chapel Allerton Hospital, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds,
UK.
PhD, FRCPIArticle Figures & Data
Figures
In this issue
The Journal of Rheumatology
Vol. 43, Issue 1
1 Jan 2016
The Need for Biological Outcomes for Biological Drugs in Psoriatic Arthritis
AI LYN TAN, DENNIS McGONAGLE
The Journal of Rheumatology Jan 2016, 43 (1) 3-6; DOI: 10.3899/jrheum.151296